Abstract--Adrenergic stimulation increases stroke volume in mammalian hearts as a result of protein kinase A (PKA)-induced phosphorylation of several myocyte proteins. This study investigated whether PKA-induced phosphorylation of myofibrillar proteins directly affects myocyte contractility. To test this possibility, we compared isometric force, loaded shortening velocity, and power output in skinned rat cardiac myocytes before and after treatment with the catalytic subunit of PKA. Consistent with previous studies, PKA increased phosphorylation levels of myosin binding protein C and troponin I, and reduced Ca 2ϩ sensitivity of force. PKA also significantly increased both maximal force (25.4Ϯ8.3 versus 31.6Ϯ11.3 N [PϽ0.001, nϭ12]) and peak absolute power output (2.48Ϯ1.33 versus 3.38Ϯ1.52 W/mg [PϽ0.05, nϭ5]) during maximal Ca 2ϩ activations. Furthermore, PKA elevated power output at nearly all loads even after normalizing for the increase in force. After PKA treatment, peak normalized power output increased Ϸ20% during maximal Ca 2ϩ activations (nϭ5) and Ϸ33% during half-maximal Ca 2ϩ activations (nϭ9). These results indicate that PKA-induced phosphorylation of myofibrillar proteins increases the power output-generating capacity of skinned cardiac myocytes, in part, by speeding the step(s) in the crossbridge cycle that limit loaded shortening rates, and these changes likely contribute to greater contractility in hearts after -adrenergic stimulation. Key Words: cardiac myocytes Ⅲ -adrenergic stimulation Ⅲ cardiac contractility Ⅲ sarcomere proteins Ⅲ protein kinase A M yocardial performance is enhanced when -adrenergic receptors are stimulated by catecholamines. After -adrenergic receptor stimulation, myocardial performance is associated with increased force development and faster rates of both the rise and fall of force. 1 These positive inotropic and lusitropic effects are mediated by 3Ј-5Ј cAMP-dependent protein kinase (protein kinase A [PKA]), which phosphorylates several proteins inside cardiac myocytes including the sarcolemmal Ca 2ϩ channel, the ryanodine receptor, 2 phospholamban, troponin I (TnI), and myosin binding protein C (MyBP-C). 3 Four of these phosphoproteins (the sarcolemmal Ca 2ϩ channel, ryanodine receptor, phospholamban, and TnI) are involved with the handling of intracellular Ca 2ϩ , and the phosphorylation state of these proteins regulates both the amplitude and duration of the Ca 2ϩ transient. Therefore, it is generally accepted that Ca 2ϩ handling is an important molecular mechanism underlying the inotropic effects of -adrenergic receptor stimulation. 4,5 However, changes in Ca 2ϩ handling may not be the sole mechanism responsible for the inotropic effects of -adrenergic receptor stimulation, given that the rise and fall of the Ca 2ϩ transient and the binding of Ca 2ϩ to troponin C all appear to be too rapid to limit the rise and fall of pressure during a heartbeat. 6 Thus, the factors that determine the rise and fall of pressure during a heartbeat also likely reside, at least in par...